Jarro-Dophilus® Prenatal supports a healthy pregnancy for mother and baby.* This unique formula includes four patented, clinically documented vaginal probiotic strains from the predominant protective bacterial species found in healthy vaginal flora; L. crispatus LbV 88, L. jensenii LbV 116, L. gasseri LbV 150N, and L. rhamnosus LbV 96. Additionally it contains, clinically documented Bifidobacterium longum subsp. infantis M-63, a probiotic strain associated with improved growth of newborns.*
Supports Intestinal and Urogenital Health During Maternity*
Helps to maintain healthy flora of the intestinal and vaginal tracts to support mother and baby throughout pregnancy.*
Better Stability of Probiotics
Jarro-Dophilus® Prenatal is packaged in an Activ-Vial™ moisture-controlled desiccant bottle to help enhance the stability of probiotics.
Take 1 capsule per day, with water, preferably on an empty stomach, or take as directed by your qualified healthcare professional.
NOTE: Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition; if adverse reactions occur, discontinue use.
No Refrigeration Necessary
Does not require refrigeration and can be stored at room temperature in cool, dry place. Avoid storage at temperature above 77°F (25°C). Refrigeration, however extends shelf life.
Live Probiotic Guarantee
When kept under recommended storage conditions, Jarrow® Probiotics are formulated to ensure CFU counts are guaranteed within Best Used Before date.
Keep out of reach of children.
Corn starch, sodium alginate (algae derived), DRcaps® (hydroxypropylmethylcellulose, water), maltodextrin, calcium phosphate, tapioca starch, sucrose and silicon dioxide.
No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.
DRcaps® (delayed release capsules) help assure survival of viable cells by minimizing exposure to stomach acid.
DRcaps® is a trademark of Lonza or its affiliates.
Clinically documented Strains Matter™
Protected by U.S. Patent 8,846,027 and European Patent 2,509,610, which are owned by HSO Health Care GmbH, Vienna, Austria, and licensed in the U.S. to Jarrow Formulas, Inc. Other international patents pending.
Sold worldwide as Astarte.